[ALA] YoY Quarter Result on 31-Dec-2018 [#Q2]

Stock
[ALA] Arovella Therapeutics Limited
Announcement Date
30-Dec-2018
Financial Year
2019
Quarter
31-Dec-2018 [#Q2]
Profit Trend
QoQ- 0.00%
YoY- 60.92%
Quarter Report
ALA's Result
ALA's Financial Summary
View:
Show?
Quarter Result
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
Revenue 23 243 370 427 202 195 1,419 -49.66%
PBT -3,950 -1,756 -7,699 -435 -1,113 -527 -906 27.78%
Tax -0 -9 0 0 0 56 0 -
NP -3,950 -1,747 -7,699 -435 -1,113 -471 -906 27.78%
Tax Rate - - - - - - - -
Total Cost 3,973 1,990 8,069 862 1,315 666 2,325 9.33%
Ratio Analysis
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
NP Margin -17,484.78 -720.44 -2,081.94 -101.83 -551.87 -240.94 -63.82 154.63%
Per Share
31/12/21 31/12/20 31/12/19 31/12/18 31/12/17 31/12/16 31/12/15 CAGR
EPS -0.01 -0.01 -0.05 -0.00 -0.02 -0.01 -0.02 -10.90%
EPS Diluted -0.01 -0.01 -0.05 -0.00 -0.02 -0.01 -0.02 -10.90%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.